Treatment Expectations
SMA HCP Education | 14 Sep 2020 | Speaker: Dr. Ricardo Masson | Italy
Dr. Masson, Neuromuscular expert from Italy, explains the physician standpoint on treatment expectations from the evolving phenotypes of pediatric SMA patients. Dr. Masson also shares how to also effectively manage patient's and caregiver's expectations from SMA therapy.
Treatment Expectations
https://smadisease.global/https://www.smadisease.in/home/videos/treatment-expectations.html
Related Videos
Speaker: Professor Eduardo Tizzano
Dr. Tizzano, Neuromuscular expert from Spain, goes deeper into the evolving phenotypes of SMA with therapy.
Speakers: Dr. Ricardo Masson
Dr. Masson, Neuromuscular expert from Italy, shares his perspectives on frequently
asked questions from healthcare practitioners (HCPs) from around the world.
Speakers: Professor Eduardo Tizzano
Prof. Tizzano, Neuromuscular expert from Spain, explains the step by step process to
diagnose SMA.
Speaker: Dr. Ricardo Masson
Dr. Masson, Neuromuscular expert from Italy, explains the significance of SMN protein in motor neurons, CNS as well as throughout the body
Speaker: Professor Michelle Farrar
Associate Professor Michelle Farrar discusses the merits of New born screening for initiating early treatment in SMA
Speaker: Professor Michelle Farrar
Associate Professor Michelle Farrar discusses the SMA phenotypes that are emerging from disease modifying therapies (DMTs) in SMA
Speaker: Professor Michelle Farrar
Associate Professor Michelle Farrar discusses the SMA phenotypes that are emerging from disease modifying therapies (DMTs) in SMA
Speaker: Dr. Ricardo Masson
Dr. Masson, Neuromuscular expert from Italy, stresses the importance of accurate early diagnosis of SMA
Speaker: Dr. Anna Mayhew
Dr. Anna Mayhew explains the importance of measuring patient-centred outcomes in SMA and aspects to consider when choosing scales to assess patients
Speaker: Dr. Anna Mayhew
Dr. Anna Mayhew presents the most commonly used motor performance scales suitable for Type II and Type III Spinal Muscular Atrophy.
Speaker: Dr. Anna Mayhew
Dr. Anna Mayhew presents the most commonly used scales for outcome measures in Type I Spinal Muscular Atrophy.
Speaker: Professor Nicolas Deconinck
In this video Prof. Deconinck gives an overview what to consider in interpretation and assessment of clinical trials in SMA.
Speaker: Professor Wolfgang Müller-Felber
Professor Müller-Felber discusses the chances of optimal development that newborn screening offers for SMA patients.
Speaker: Professor Maggie C. Walter
Professor Walter discusses therapeutic results expected for SMA patients based on
type and treatment options.
Speaker: Professor Eugenio Mercuri
In this video Prof Mercuri introduces his team and the topics that will be covered by this SMA Disease Management Experience series.
Speaker: Dottssa Giorgia Coratti
In this video Dottssa Coratti explains how the evolving therapeutic landscape in SMA is impacting the course of the disease and the model of care for patients.
Speaker: Dottssa Maria Carmela Pera
In this video Dottssa Pera gives an overview of clinical trials in SMA.